Recent progress in pancreatic cancer
CL Wolfgang, JM Herman, DA Laheru… - CA: a cancer journal …, 2013 - Wiley Online Library
Answer questions and earn CME/CNE Pancreatic cancer is currently one of the deadliest of
the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and …
the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and …
Pancreatic cancer
Substantial progress has been made in our understanding of the biology of pancreatic
cancer, and advances in patients' management have also taken place. Evidence is …
cancer, and advances in patients' management have also taken place. Evidence is …
[HTML][HTML] Proteogenomic characterization of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor patient
survival. Toward understanding the underlying molecular alterations that drive PDAC …
survival. Toward understanding the underlying molecular alterations that drive PDAC …
Pancreatic cancer
M Hidalgo - New England journal of medicine, 2010 - Mass Medical Soc
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank
fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer …
fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer …
[HTML][HTML] Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection
AE Becker, YG Hernandez, H Frucht… - World journal of …, 2014 - ncbi.nlm.nih.gov
Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United
States, with over 38000 deaths in 2013. The opportunity to detect pancreatic cancer while it …
States, with over 38000 deaths in 2013. The opportunity to detect pancreatic cancer while it …
[HTML][HTML] The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal
UK Ballehaninna, RS Chamberlain - Journal of gastrointestinal …, 2012 - ncbi.nlm.nih.gov
Background Serum carbohydrate antigen (CA 19-9) is the most common tumor marker
assessed in pancreatic cancer patients; nevertheless few articles have comprehensively …
assessed in pancreatic cancer patients; nevertheless few articles have comprehensively …
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
J Kim, WR Bamlet, AL Oberg, KG Chaffee… - Science translational …, 2017 - science.org
Markers are needed to facilitate early detection of pancreatic ductal adenocarcinoma
(PDAC), which is often diagnosed too late for effective therapy. Starting with a PDAC cell …
(PDAC), which is often diagnosed too late for effective therapy. Starting with a PDAC cell …
GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop
J Montojo, K Zuberi, H Rodriguez, F Kazi… - …, 2010 - academic.oup.com
The GeneMANIA Cytoscape plugin brings fast gene function prediction capabilities to the
desktop. GeneMANIA identifies the most related genes to a query gene set using a guilt-by …
desktop. GeneMANIA identifies the most related genes to a query gene set using a guilt-by …
[HTML][HTML] Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China
Z Ren, J Jiang, H Xie, A Li, H Lu, S Xu, L Zhou… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Pancreatic carcinoma (PC) is a lethal cancer. Gut microbiota is associated with some risk
factors of PC, eg obesity and types II diabetes. However, the specific gut microbial profile in …
factors of PC, eg obesity and types II diabetes. However, the specific gut microbial profile in …